PDT Partners LLC decreased its position in shares of athenahealth, Inc. (NASDAQ:ATHN) by 77.7% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 13,900 shares of the health services provider’s stock after selling 48,490 shares during the period. PDT Partners LLC’s holdings in athenahealth were worth $1,954,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in ATHN. FMR LLC lifted its holdings in athenahealth by 0.8% in the 2nd quarter. FMR LLC now owns 5,975,119 shares of the health services provider’s stock worth $839,803,000 after buying an additional 47,341 shares in the last quarter. Morgan Stanley boosted its position in athenahealth by 9.7% in the 1st quarter. Morgan Stanley now owns 4,514,305 shares of the health services provider’s stock valued at $508,717,000 after buying an additional 397,837 shares during the last quarter. Vanguard Group Inc. boosted its position in athenahealth by 1.8% in the 2nd quarter. Vanguard Group Inc. now owns 3,100,643 shares of the health services provider’s stock valued at $435,795,000 after buying an additional 53,361 shares during the last quarter. BlackRock Inc. boosted its position in athenahealth by 2.0% in the 2nd quarter. BlackRock Inc. now owns 1,631,993 shares of the health services provider’s stock valued at $229,377,000 after buying an additional 32,146 shares during the last quarter. Finally, Clearbridge Investments LLC boosted its position in athenahealth by 61.8% in the 1st quarter. Clearbridge Investments LLC now owns 908,505 shares of the health services provider’s stock valued at $102,379,000 after buying an additional 347,133 shares during the last quarter.

athenahealth, Inc. (ATHN) opened at 123.51 on Wednesday. athenahealth, Inc. has a one year low of $90.11 and a one year high of $158.66. The stock’s 50 day moving average is $132.79 and its 200 day moving average is $129.75. The firm has a market cap of $4.93 billion, a P/E ratio of 156.74 and a beta of 1.76.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings data on Thursday, July 20th. The health services provider reported $0.51 earnings per share for the quarter, beating the consensus estimate of $0.39 by $0.12. athenahealth had a return on equity of 6.91% and a net margin of 2.80%. The company had revenue of $301.10 million for the quarter, compared to analyst estimates of $298.68 million. During the same period in the prior year, the company posted $0.34 EPS. The company’s revenue was up 15.0% compared to the same quarter last year. On average, equities research analysts expect that athenahealth, Inc. will post $1.91 earnings per share for the current year.

In other athenahealth news, SVP Jonathan D. Porter sold 422 shares of the company’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $154.00, for a total value of $64,988.00. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Jonathan Bush sold 4,000 shares of the stock in a transaction on Tuesday, August 1st. The stock was sold at an average price of $143.31, for a total value of $573,240.00. Following the transaction, the chief executive officer now owns 319,807 shares of the company’s stock, valued at $45,831,541.17. The disclosure for this sale can be found here. Insiders have sold a total of 16,505 shares of company stock valued at $2,240,851 in the last 90 days. 3.20% of the stock is owned by corporate insiders.

Several research firms recently commented on ATHN. ValuEngine upgraded athenahealth from a “sell” rating to a “hold” rating in a research note on Monday, July 24th. Evercore ISI reissued an “outperform” rating and issued a $163.00 price target (up previously from $155.00) on shares of athenahealth in a report on Saturday, July 22nd. Cowen and Company lowered athenahealth from an “outperform” rating to a “market perform” rating and raised their price objective for the company from $127.00 to $133.00 in a research note on Monday, July 31st. Jefferies Group LLC restated a “hold” rating and set a $135.00 price objective on shares of athenahealth in a research note on Monday, June 26th. Finally, Stifel Nicolaus restated a “hold” rating and set a $151.00 price objective (up from $106.00) on shares of athenahealth in a report on Friday, June 16th. Three research analysts have rated the stock with a sell rating, twelve have assigned a hold rating and twelve have given a buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus target price of $149.91.

TRADEMARK VIOLATION WARNING: “PDT Partners LLC Has $1.95 Million Position in athenahealth, Inc. (ATHN)” was originally posted by Marea Informative and is owned by of Marea Informative. If you are reading this report on another site, it was illegally copied and reposted in violation of United States & international copyright laws. The original version of this report can be viewed at http://www.mareainformativa.com/pdt-partners-llc-has-1-95-million-position-in-athenahealth-inc-athn/115170/.

About athenahealth

athenahealth, Inc provides network-based medical record, revenue cycle, patient engagement, care coordination and population health services. The Company also offers Epocrates and other point-of-care mobile applications. The Company delivers majority of its service offerings through a single instance of cloud-based software, athenaNet.

Want to see what other hedge funds are holding ATHN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for athenahealth, Inc. (NASDAQ:ATHN).

Institutional Ownership by Quarter for athenahealth (NASDAQ:ATHN)

Receive News & Stock Ratings for athenahealth Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth Inc. and related stocks with our FREE daily email newsletter.